DOJ Drops Motion Against Ranbaxy
After a war of words earlier this summer, the U.S. Department of Justice has taken a motion regarding the production of audit reports in an investigation of Indian pharmaceutical company Ranbaxy...To view the full article, register now.
Already a subscriber? Click here to view full article